Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)

BACKGROUND: The REVOLENS study compared lung volume reduction coil treatment to usual care in patients with severe emphysema at 1 year, resulting in improved quality-adjusted life-year (QALY) and higher costs. Durability of the coil treatment benefit and its cost-effectiveness at 2 years are now ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulsei, Julie, Leroy, Sylvie, Perotin, Jeanne-Marie, Mal, Hervé, Marquette, Charles-Hugo, Dutau, Hervé, Bourdin, Arnaud, Vergnon, Jean-Michel, Pison, Christophe, Kessler, Romain, Jounieaux, Vincent, Salaün, Mathieu, Marceau, Armelle, Dukic, Sylvain, Barbe, Coralie, Bonnaire, Margaux, Deslee, Gaëtan, Durand-Zaleski, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941693/
https://www.ncbi.nlm.nih.gov/pubmed/29743071
http://dx.doi.org/10.1186/s12931-018-0796-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941693/
https://www.ncbi.nlm.nih.gov/pubmed/29743071
http://dx.doi.org/10.1186/s12931-018-0796-x

Ejemplares similares